Corrigendum to "The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection" [Antivir. Res. vol 192 (2021) 1-13/105121]

Affiliations

¹ Department of Virology, Institute of Tropical Medicine and Leading Program, Graduate School of Biomedical Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
² Department of Virology 1, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama City, Tokyo, 208-0011, Japan.
³ Central Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu, Bagmati, 44601, Nepal.
⁴ National Research Center for the Control and Prevention of Infectious Diseases (CCPID), Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
⁵ Department of Immune Regulation, Shionogi Global Infectious Diseases Division, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
⁶ Laboratory of Veterinary Microbiology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, 753-8515, Japan.
⁷ Department of Virology, Institute of Tropical Medicine and Leading Program, Graduate School of Biomedical Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan. Electronic address: moritak@nagasaki-u.ac.jp.
⁸ Department of Virology, Institute of Tropical Medicine and Leading Program, Graduate School of Biomedical Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan. Electronic address: myamyat@tm.nagasaki-u.ac.jp.

Published Erratum

Sandra Kendra Raini et al. Antiviral Res. 2022 Mar.

. 2022 Mar:199:105245.

doi: 10.1016/j.antiviral.2022.105245. Epub 2022 Feb 1.

¹ Department of Virology, Institute of Tropical Medicine and Leading Program, Graduate School of Biomedical Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
² Department of Virology 1, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama City, Tokyo, 208-0011, Japan.
³ Central Department of Microbiology, Tribhuvan University, Kirtipur, Kathmandu, Bagmati, 44601, Nepal.
⁴ National Research Center for the Control and Prevention of Infectious Diseases (CCPID), Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
⁵ Department of Immune Regulation, Shionogi Global Infectious Diseases Division, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
⁶ Laboratory of Veterinary Microbiology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, 753-8515, Japan.
⁷ Department of Virology, Institute of Tropical Medicine and Leading Program, Graduate School of Biomedical Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan. Electronic address: moritak@nagasaki-u.ac.jp.
⁸ Department of Virology, Institute of Tropical Medicine and Leading Program, Graduate School of Biomedical Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan. Electronic address: myamyat@tm.nagasaki-u.ac.jp.

No abstract available

Erratum for

The novel therapeutic target and inhibitory effects of PF-429242 against Zika virus infection.
Raini SK, Takamatsu Y, Dumre SP, Urata S, Mizukami S, Moi ML, Hayasaka D, Inoue S, Morita K, Ngwe Tun MM. Raini SK, et al. Antiviral Res. 2021 Aug;192:105121. doi: 10.1016/j.antiviral.2021.105121. Epub 2021 Jun 24. Antiviral Res. 2021. PMID: 34175321